ctrl K

Passage Bio Inc. (PASG)

NASDAQ: PASG · Real-Time Price · USD

0.41

0.07 (22.35%)

At close: May 02, 2025, 3:59 PM

0.39

-4.39%

After-hours: May 02, 2025, 04:54 PM EDT

Passage Bio Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	3.72M	3.68M	1.54M	800K	134K	n/a
Gross Profit	n/a	-3.72M	-3.68M	-1.54M	-800K	-134K	n/a
Operating Income	-70.4M	-108.39M	-138.39M	-185.73M	-112.9M	-37.19M	-13.47M
Interest Income	n/a	5.6M	2.27M	343K	670K	696K	n/a
Pretax Income	-64.77M	-102.06M	-136.13M	-185.39M	-112.23M	-45.63M	-12.77M
Net Income	-64.77M	-102.06M	-136.86M	-191.5M	-111.76M	-54.58M	-12.77M
Selling & General & Admin	24.99M	41.58M	49.34M	60.06M	30.11M	6.95M	928K
Research & Development	40.18M	61.42M	86.05M	117.67M	81.79M	29.74M	9.17M
Other Expenses	n/a	5.39M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	65.17M	108.39M	135.39M	177.73M	111.9M	36.69M	10.1M
Interest Expense	n/a	n/a	2.27M	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	108.39M	135.39M	177.73M	111.9M	36.69M	10.1M
Income Tax Expense	-1	n/a	731K	6.11M	-470K	8.95M	-696K
Shares Outstanding (Basic)	60.41M	54.74M	54.43M	53.34M	38.62M	45.8M	23.96M
Shares Outstanding (Diluted)	60.41M	54.74M	54.43M	53.34M	38.62M	45.8M	23.96M
EPS (Basic)	-1.07	-1.86	-2.51	-3.59	-2.89	-1.19	-0.53
EPS (Diluted)	-1.07	-1.86	-2.51	-3.59	-2.89	-1.19	-0.53
EBITDA	-61.69M	-98.34M	-138.39M	-185.73M	-112.9M	-36.55M	-12.77M
EBIT	n/a	-102.06M	-136.13M	-185.39M	-112.23M	-36.69M	-12.77M
Depreciation & Amortization	n/a	3.72M	3.68M	1.54M	800K	134K	10.1M